NCT04760262

Brief Summary

One-lung ventilation (OLV) may cause negative changes in the oxygenation of cerebral tissue which results in postoperative cognitive dysfunction. The aim of this prospective study was to compare the potential effects of TIVA and inhalation general anesthesia techniques on cerebral tissue oxygenation and postoperative cognitive functions in patients receiving one-lung ventilation in thoracic surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 10, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 18, 2021

Completed
Last Updated

February 18, 2021

Status Verified

February 1, 2021

Enrollment Period

2.3 years

First QC Date

February 10, 2021

Last Update Submit

February 17, 2021

Conditions

Keywords

One-lung ventilationcerebral oxygenationpostoperative cognitive dysfunctionsevofluranepropofol

Outcome Measures

Primary Outcomes (2)

  • Near Infrared Spectroscopy

    Cerebral oxygen saturation as measured by Near Infrared Spectroscopy

    Duration of surgery

  • Mini mental state examination (MMSE)

    Mini mental state examination (MMSE) to evaluate patients' cognitive functions

    3 to 24 hours postoperative period

Secondary Outcomes (3)

  • mean arterial pressure

    Duration of surgery

  • heart rate

    Duration of surgery

  • bispectral index

    Duration of surgery

Study Arms (2)

Group Propofol

anesthesia was maintained with TIVA (intravenous 125-250 µg/kg/min propofol + 0.1-0.25 µg/kg/min remifentanil infusion)

Drug: Propofol

Group Sevoflurane

anesthesia was maintained with inhalation (sevoflurane concentration of 1-2% in 50-50% O2-air mixture).

Drug: Sevoflurane

Interventions

Sevoflurane %2-3 for general anesthesia maintenance, BIS values were arranged 40-60 until the end of operation, In case of tachycardia or hypertension the opioid dose was reduced, in case of bradycardia or hypertension the opioid dose was increased

Group Sevoflurane

BIS values were arranged 40-60 until the end of operation, In case of tachycardia or hypertension the opioid dose was reduced, in case of bradycardia or hypertension the opioid dose was increased

Also known as: Remifentanil
Group Propofol

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who would undergo thoracic surgery with one-lung ventilation (OLV)

You may qualify if:

  • Patients in American Society of Anesthesiology (ASA) classification I and II
  • Patients who would undergo thoracic surgery with one-lung ventilation (OLV)
  • thoracic surgeries with one-lung ventilation (OLV) that will take at least 45 minutes

You may not qualify if:

  • Patients in ASA classification III and higher
  • Emergency surgery
  • Patients with known allergy to drugs used in the study
  • Patients in New York Heart Association classification III-IV
  • severe metabolic, renal, hepatic, central nervous system diseases, alcohol or drug addiction
  • multiple trauma, coagulapathy, cerebral disease, dementia, hearing impairment and imperception
  • severe obesity (a body mass index (BMI) of ≥ 35)
  • patients with a peripheral oxygen saturation below 90 during one lung ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karadeniz Technical University

Trabzon, 61080, Turkey (Türkiye)

Location

Related Publications (5)

  • Hood R, Budd A, Sorond FA, Hogue CW. Peri-operative neurological complications. Anaesthesia. 2018 Jan;73 Suppl 1:67-75. doi: 10.1111/anae.14142.

    PMID: 29313909BACKGROUND
  • Nakayama M, Murray PA. Ketamine preserves and propofol potentiates hypoxic pulmonary vasoconstriction compared with the conscious state in chronically instrumented dogs. Anesthesiology. 1999 Sep;91(3):760-71. doi: 10.1097/00000542-199909000-00029.

    PMID: 10485788BACKGROUND
  • Kazan R, Bracco D, Hemmerling TM. Reduced cerebral oxygen saturation measured by absolute cerebral oximetry during thoracic surgery correlates with postoperative complications. Br J Anaesth. 2009 Dec;103(6):811-6. doi: 10.1093/bja/aep309.

    PMID: 19918024BACKGROUND
  • Mahal I, Davie SN, Grocott HP. Cerebral oximetry and thoracic surgery. Curr Opin Anaesthesiol. 2014 Feb;27(1):21-7. doi: 10.1097/ACO.0000000000000027.

    PMID: 24263686BACKGROUND
  • Aguirre JA, Marzendorfer O, Brada M, Saporito A, Borgeat A, Buhler P. Cerebral oxygenation in the beach chair position for shoulder surgery in regional anesthesia: impact on cerebral blood flow and neurobehavioral outcome. J Clin Anesth. 2016 Dec;35:456-464. doi: 10.1016/j.jclinane.2016.08.035. Epub 2016 Oct 18.

    PMID: 27871574BACKGROUND

MeSH Terms

Conditions

Postoperative Cognitive Complications

Interventions

SevofluranePropofolRemifentanil

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsCognitive DysfunctionCognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Methyl EthersEthersOrganic ChemicalsHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbonsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

February 10, 2021

First Posted

February 18, 2021

Study Start

March 1, 2017

Primary Completion

June 15, 2019

Study Completion

January 20, 2020

Last Updated

February 18, 2021

Record last verified: 2021-02

Locations